November/December 2005


In this Issue

Glaucoma Today


Comparing Prostaglandins

How they work singularly and in combination therapies.

By George Shafranov, MD

Phacomorphic Glaucoma

By Michael Maley, MD; Lesya Shuba, MD, PhD; and Young H. Kwon, MD, PhD

Under the Microscope

What puts a practice at risk for an audit?

By Patricia M. Salmon, CHBC

Surgical Management of Angle Closure

Medical therapies are helpful, but surgery remains the definitive treatment.

By Molly M. Walsh, MD, MPH, and Paul P. Lee, MD, JD

Criteria for Visual Field Progression

Insights from the Collaborative Normal-Tension Glaucoma Study and the Early Manifest Glaucoma Study.

By Donald Budenz, MD, MPH

Developments in Neuroprotection

Novel neuroprotective agents and their mechanisms.

By Daniel Hwang, MA; Li Wu, MD; and James C. Tsai, MD

Disease Progression in Glaucoma

Some diagnostic pearls and controversies in management.

By Arthur J. Sit, SM, MD; Jonathan G. Crowston MD, PhD; and Robert N. Weinreb, MD; With Donald S. Minckler, MD

5 Questions With Murray Johnstone, MD

By Murray Johnstone, MD

The Value of Stereoscopic Optic Disc Photography

An update on imaging techniques and reliability.

By Stuart J. McKinnon, MD, PhD

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.